Shima Hadidchi MDs practice with obesity, high blood pressure, type 2 diabetes, or high cholesterol
Prompt recognition and appropriate response to potential gallbladder symptoms can prevent serious complications in patients taking GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists
Chatham adds that tirzepatide (specifically Zepbound) has FDA approval to help treat obstructive sleep apnea in people with obesity
Type2 Diabetes Mellitus(T2DM) is associated with Obesity, Dyslipidemia, and Hypertension
Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic
Jelly Roll added that concerns about possible side effects along with not wanting an asterisk attached to his transformation also factored into his decision
